UCB Competitors and Similar CompaniesClear all
UCB's competitors and similar companies include Jazz Pharmaceuticals, Lundbeck, Amarin and Genewiz.
 UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Jazz Pharmaceuticals Jazz Pharmaceuticals is a biopharmaceutical company engaged in developing and marketing medicines for sleep disorders, epilepsy, and oncology. |  Amarin Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases. |  Genewiz GENEWIZ specializes in DNA services, including DNA sequencing, gene synthesis, molecular biology, genomic, and regulatory services. | ||
Founding Date | Founding Date 1928 | Founding Date 2003 | Founding Date 1915 | Founding Date 1991 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Dublin, IE HQ Mississauga, CA Vancouver, CA Lyon, FR München, DE Roscommon, IE Villa Guardia, IT see more | Locations København, DK HQ Buenos Aires, AR North Ryde, AU Wien, AT Bruxelles, BE Rio De Janeiro, BR Sofia, BG see more | Locations Dublin, IE HQ Zug, CH Bridgewater Township, US | |
Employees | Employees 9,052 | Employees 2,800 | Employees 5,700 | Employees 275 | Employees 139 |
Valuation ($) | Valuation ($) 34.3 b | Valuation ($) 6.9 b | Valuation ($) 6.2 b | Valuation ($) 257.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) kr24.6b (FY, 2025) | Revenue (est.) $213.6m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A | Cost of goods kr2.7b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €7.2b (FY, 2025) | Gross profit N/A | Gross profit kr22b (FY, 2025) | Gross profit $120.9m (FY, 2025) | Gross profit N/A |
Net income | Net income €1.6b (FY, 2025) | Net income ($356.1m) (FY, 2025) | Net income kr3.2b (FY, 2025) | Net income ($38.8m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries 35 (FY, 2019) | Countries N/A | Countries 100 (May, 2024) | Countries N/A | Countries N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 384.1m | Total funding raised N/A | Total funding raised $ 122.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Jazz Pharmaceuticals
HQ
Dublin, IE
Employees
2,800
Jazz Pharmaceuticals is a biopharmaceutical company engaged in developing and marketing medicines for sleep disorders, epilepsy, and oncology.
View company
Lundbeck
HQ
København, DK
Employees
5,700
H. Lundbeck is a pharmaceutical company specializing in brain diseases.
View companyAmarin
HQ
Dublin, IE
Employees
275
Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.
View companyGenewiz
HQ
South Plainfield, US
Employees
139
GENEWIZ specializes in DNA services, including DNA sequencing, gene synthesis, molecular biology, genomic, and regulatory services.
View company